Background: The new Drugs and Clinical Trial Rules, 2019 have been published with effect from 19th March 2019 with a view to regulate New Drugs, Investigational New Drugs for human use, Clinical trials, bioequivalence study, bioavailability, and ethics committee. The…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.